Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psychiatry].

G Bertschy1, R Barbe, N Gervasoni

  • 1Service de psychiatrie adulte, HUG, Chêne-Bourg. gilles.bertschy@hcuge.ch

Revue Medicale Suisse
|February 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision medicine strategy in pancreatic ductal adenocarcinoma.

ESMO open·2025
Same author

Safety and tolerance of combination of monoamine oxidase inhibitors and direct dopamine agonists in adults and older adults with highly resistant depression.

L'Encephale·2023
Same author

Impact of the first wave of the COVID-19 pandemic on French Health students.

L'Encephale·2022
Same author

Misdiagnosis in three boys with predominantly hyperactive ADHD.

L'Encephale·2020
Same author

Racing and crowded thoughts in mood disorders: A data-oriented theoretical reappraisal.

L'Encephale·2020
Same author

Incidence and risk factors of venous thromboembolism: Peculiarities in psychiatric institutions.

International journal of cardiology·2017
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Selective serotonin reuptake inhibitors may slightly increase suicidal behavior risk, not death risk. Caution is advised for children and adolescents, as drug benefits are unclear in this group.

Area of Science:

  • Psychiatry and Pharmacology
  • Mental Health Research

Background:

  • In 2005, significant debate surrounded the risk of suicide associated with selective serotonin reuptake inhibitors (SSRIs).
  • Concerns were raised regarding the safety profile of SSRIs, particularly in younger populations.

Purpose of the Study:

  • To review the evidence on the risk of suicidal behavior and death by suicide during SSRI treatment.
  • To synthesize recent advancements in cognitive psychotherapy for depression and pharmacotherapy for borderline personality disorder.

Main Methods:

  • Systematic review of studies examining SSRI treatment and suicidal behavior.
  • Synthesis of literature on recent developments in psychotherapy and pharmacotherapy for specific mental health conditions.

Main Results:

Related Experiment Videos

  • A moderate increase in the risk of suicidal behavior was identified, but not an increased risk of death by suicide.
  • Cognitive psychotherapy for depressive disorders shows promising developments.
  • Pharmacotherapy for borderline personality disorder has seen no major breakthroughs.

Conclusions:

  • SSRIs should be used with caution, especially in children and adolescents, due to an unclear benefit-risk balance.
  • The findings suggest a need for careful monitoring rather than widespread panic regarding SSRI use.
  • Further research into effective treatments for depression and personality disorders remains crucial.